ERCC5
Basic information
Region (hg38): 13:102845831-102875995
Previous symbols: [ "ERCM2", "XPGC" ]
Links
Phenotypes
GenCC
Source:
- xeroderma pigmentosum group G (Definitive), mode of inheritance: AR
- xeroderma pigmentosum group G (Strong), mode of inheritance: AR
- cerebrooculofacioskeletal syndrome 3 (Limited), mode of inheritance: AR
- xeroderma pigmentosum group G (Definitive), mode of inheritance: AR
- COFS syndrome (Supportive), mode of inheritance: AR
- xeroderma pigmentosum (Supportive), mode of inheritance: AR
- xeroderma pigmentosum-Cockayne syndrome complex (Supportive), mode of inheritance: AR
- cerebrooculofacioskeletal syndrome 3 (Strong), mode of inheritance: AR
- xeroderma pigmentosum group G (Strong), mode of inheritance: AR
- xeroderma pigmentosum group G (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Xeroderma pigmentosum, complementation group G; Xeroderma pigmentosum, complementation group G/Cockayne syndrome | AR | Dermatologic; Oncologic | Skin lesions can be treated (and possibly prevented in some cases) with a variety of methods, depending on the specific type of lesion; Sun/UV exposure (and other agents, such as tobacco smoke) should be avoided; Periodic surveillance for dermatologic manifestations can be beneficial | Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic | 492197; 11219864; 3620347; 8317483; 8818951; 9096355; 11228268; 11841555; 20301571; 24700531 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (248 variants)
- Xeroderma_pigmentosum,_group_G (142 variants)
- not_specified (78 variants)
- Hereditary_cancer-predisposing_syndrome (72 variants)
- Cerebrooculofacioskeletal_syndrome_3 (67 variants)
- Inborn_genetic_diseases (33 variants)
- ERCC5-related_disorder (22 variants)
- Xeroderma_pigmentosum (14 variants)
- BIVM-ERCC5-related_disorder (12 variants)
- Ovarian_cancer (10 variants)
- Xeroderma_pigmentosum_group_G/Cockayne_syndrome (4 variants)
- Cognitive_impairment (1 variants)
- Spastic_paraplegia (1 variants)
- Xeroderma_pigmentosum-Cockayne_syndrome_complex (1 variants)
- Abnormal_corpus_callosum_morphology (1 variants)
- Polyneuropathy (1 variants)
- See_cases (1 variants)
- Pectus_excavatum (1 variants)
- Pes_cavus (1 variants)
- Dysarthria (1 variants)
- Hepatoblastoma (1 variants)
- Cerebellar_atrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERCC5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000123.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 86 | 98 | ||||
| missense | 11 | 165 | 36 | 219 | ||
| nonsense | 18 | |||||
| start loss | 0 | |||||
| frameshift | 15 | 20 | 39 | |||
| splice donor/acceptor (+/-2bp) | 6 | |||||
| Total | 28 | 45 | 178 | 122 | 7 |
Highest pathogenic variant AF is 0.00006260941
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ERCC5 | protein_coding | protein_coding | ENST00000355739 | 15 | 31152 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.73e-13 | 0.992 | 125698 | 0 | 50 | 125748 | 0.000199 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.118 | 628 | 636 | 0.987 | 0.0000359 | 7798 |
| Missense in Polyphen | 220 | 225 | 0.97779 | 2766 | ||
| Synonymous | -0.151 | 251 | 248 | 1.01 | 0.0000157 | 2258 |
| Loss of Function | 2.64 | 28 | 47.7 | 0.587 | 0.00000243 | 580 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000301 | 0.000300 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000272 | 0.000272 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000168 | 0.000167 |
| Middle Eastern | 0.000272 | 0.000272 |
| South Asian | 0.000621 | 0.000621 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too.;
- Disease
- DISEASE: Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. Some XP-G patients present features of Cockayne syndrome, cachectic dwarfism, pigmentary retinopathy, ataxia, decreased nerve conduction velocities. The phenotype combining xeroderma pigmentosum and Cockayne syndrome traits is referred to as XP-CS complex. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:11228268, ECO:0000269|PubMed:11841555, ECO:0000269|PubMed:12060391, ECO:0000269|PubMed:23255472, ECO:0000269|PubMed:7951246, ECO:0000269|PubMed:9096355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cerebro-oculo-facio-skeletal syndrome 3 (COFS3) [MIM:616570]: A disorder of prenatal onset characterized by microcephaly, congenital cataracts, facial dysmorphism, neurogenic arthrogryposis, growth failure and severe psychomotor retardation. COFS is considered to be part of the nucleotide-excision repair disorders spectrum that include also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome. {ECO:0000269|PubMed:24700531}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Nucleotide excision repair - Homo sapiens (human);Nucleotide Excision Repair ;DNA Repair;Formation of Incision Complex in GG-NER;Dual Incision in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair
(Consensus)
Recessive Scores
- pRec
- 0.493
Intolerance Scores
- loftool
- 0.898
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.13
Haploinsufficiency Scores
- pHI
- 0.0814
- hipred
- Y
- hipred_score
- 0.572
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.843
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ercc5
- Phenotype
- digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- transcription-coupled nucleotide-excision repair;nucleotide-excision repair;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;response to UV;UV protection;response to UV-C;nucleotide-excision repair, DNA incision;negative regulation of apoptotic process
- Cellular component
- nucleotide-excision repair complex;nucleus;nucleoplasm;DNA replication factor A complex
- Molecular function
- bubble DNA binding;RNA polymerase II complex binding;double-stranded DNA binding;single-stranded DNA binding;endodeoxyribonuclease activity;protein binding;protein homodimerization activity;protein-containing complex binding;metal ion binding;protein N-terminus binding